Letters to the Editor

References

• Barbeau A. L-Dopa and juvenile Huntington's Disease. Lancet 1969; ii: 1066
   Google Scholar
• Beal M. F., Kowall N. W., Ellinson D. W., Mazurek M. F., Swartz K. J., Martin J. Nature 1986; 321: 168–171, B. Replication of the neurochemical characteristics of Huntington's Disease by quinolinic acid.;
   PubMed Web of Science ®Google Scholar
• Belendiuk L., Belendiuk G. W., Freedman D. X. Blood monoamine metabolism in Huntington's Disease. Archives of General Psychiatry 1980; 37: 325–332
   PubMed Web of Science ®Google Scholar
• Boman B. L-tryptophan: A rational anti-depressant and a natural hypnotic. Australian and New Zealand Journal of Psychiatry 1988; 22: 83–97
   PubMed Web of Science ®Google Scholar
• Bucci L., Ioppolo A., Chiaverelli A. R., Bigotti A. The central nervous system toxicity of long-term oral administration of L-tryptophan to porto-caval-shunted rats. British Journal of Experimental Pathology 1982; 63: 235–241
   PubMedGoogle Scholar
• During M. J., Freeze A., Heyes M. P., Swartz K. J., Markey S. P., Roth R. H., Martin J. B. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid: Effect of systemic tryptophan administration, Submitted for publication
   Google Scholar
• Gousin D. B. Central nervous system hypersensitivity to tryptophan. American Journal of Clinical Nutrition 1971; 24: 821–825
   PubMed Web of Science ®Google Scholar
• Schwarcz R., Brush G. S., Foster A. C., French E. D. Seizure activity and lesions after intrahippocampal quinolinic acid injections. Experimental Neurology 1984; 84: 1–17
   PubMed Web of Science ®Google Scholar
• Stone T. W., Perkins M. N. Quinolinic Acid: A potent endogenous excitant at amino acid receptors in the rat brain. European Journal of Pharmacology 1981; 72, :411 -412
   PubMed Web of Science ®Google Scholar
• Whetsell W. O. The use of organotypic tissue culture for the study of amino acid neurotoxicity and its antagonism in the mammalian CNS. Clinical Neuropharmacology 1984; 7: 248–250
   Google Scholar
• Lawrence J. The psychiatry of leadership and the psychiatrist as leader. Australian and New Zealand Journal of Psychiatry 1988; 22: 246–256
   PubMed Web of Science ®Google Scholar
• Schioldann-Nielsen J. The life of D.G.Monrad 1811-1887. Manic-depressive disorder and political leadership. Odense University Press. 1988
   Google Scholar
• Lange-Eichbaum W, Genie Kurth W. Irrsinn und Ruhm: Genie-Mythus und Pathographie des Genies, 6th ed. Reinhardt Verlag, Munich 1967, 1979
   Google Scholar
• Gilbert Jb. Disease and destiny: A bibliography of medical references to the famous. Dawsons, London 1962
   Google Scholar
• Gilmore W. Psychohistorical inquiry: A comprehensive research bibliography. Garland, New York 1984
   Google Scholar
• Schioldann-Nielsen J. Famous and very important persons. Medical, psychological, psychiatric bibliography, 1960-1984. Odense University Press, Odense 1986
   Google Scholar
• Roos Ca. Physicians to the Presidents, and their patients: A bibliography. Bulletin of the Medical Library Association 1961; 49: 292–360
   Google Scholar
• Greenblatt M. Power and the impairment of great leaders. American Journal of Social Psychiatry 1984; 4: 11–18
   Google Scholar
• Weinstein E. Woodrow Wilson: A medical and psychological biography. Princeton University Press. 1981
   Google Scholar
• The United States Congress. Senate. Committee on the Judiciary. Subcommittee on constitutional amendments. 1963, Presidential inability; hearings before the Subcommittee … of the Committee…Eighty-eighth Congress, S.J. Res. 28, S.J. Res. 35 and S.J. Res. 84 relating to the problem of presidential inability, June 11 and June 18,1963. Washington: U.S. Government Printing Office
   Google Scholar
• Boroson W. Beyond the Twenty-fifth Amendment. Fact 1966, Sept/Oct
   Google Scholar
• Group for the Advancement of Psychiatry, Committee on Government Agencies. The VIP with psychiatric impairment. 1973; 8, Vol., Report No. 83. New York
   Google Scholar
• Torre Mp. Psychopathology and political leadership. American Journal of Psychotherapy 1970; 24: 611–626
   PubMed Web of Science ®Google Scholar
• Gambill J. Potential problems of detecting and treating psychosis in the White House. Potential psychosis in the White House. International Journal of Social Psychiatry 1980; 26: 255–262
   PubMed Web of Science ®Google Scholar
• Walsh M. Historical responsibility of the psychiatrist. Archives of General Psychiatry 1964; 11: 355–9
   PubMed Web of Science ®Google Scholar
• Moran Lord, Churchill Winston. The struggle for survival 1940-1965. Taken from the diaries of Lord Moran. Constable, London 1966
   Google Scholar
• Minas I. H., et al. Persistent psychotic symptoms at discharge in patients with schizophrenia. Australian and New Zealand Journal of Psychiatry 1988; 22: 166–172
   PubMed Web of Science ®Google Scholar
• Darcy L. Tardive dyskinesia clinic. Australian and New Zealand Journal of Psychiatry 1988; 22: 325
   Google Scholar
• Kalachnik Je, Larum Jg, Swanson A. A tardive dyskinesia monitoring policy for applied facilities. Psychopharmacology Bulletin 1983; 19: 277–282
   PubMedGoogle Scholar
• Ellard J. Where we are, and where we are going. Australian and New Zealand Journal of Psychiatry 1988; 22: 258–263
   PubMed Web of Science ®Google Scholar
• American Journal of Psychiatry 1951; 107: 868–869, Historical Notes. The word “psychiatry”
   Web of Science ®Google Scholar
• Stromgren E. Who has first used the word “psychiatry”. Medicinsk Forum (Copenhagen) 1952; 5: 238–240
   Google Scholar
• Mechler A. Das Wort “Psychiatrie”. Historische Anmerkungen. Nervenarzt 1963; 34: 405–406
   PubMedGoogle Scholar
• Pelicier Y. Histoire de la psychiatrie. Presses Universitaires de France. 1971
   Google Scholar